JAGUAR HEALTH, INC. Amortization of Debt Discount (Premium)
JAGUAR HEALTH, INC. (JAGX) reported Amortization of Debt Discount (Premium) of $432.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-19
- JAGUAR HEALTH, INC. amortization of debt discount (premium) for the quarter ending 2018-03-31 was -$107.17K.
- JAGUAR HEALTH, INC. amortization of debt discount (premium) for fiscal 2015 was $521.29K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|
| 2026-06-30 | $432.00K 10-Q · filed 2026-08-19 | ||
| 2018-03-31 | -$107.17K 10-Q · filed 2018-05-15 | ||
| 2015-12-31 | $521.29K 10-K · filed 2017-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |